BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31912365)

  • 41. Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience.
    Raverot G; Sturm N; de Fraipont F; Muller M; Salenave S; Caron P; Chabre O; Chanson P; Cortet-Rudelli C; Assaker R; Dufour H; Gaillard S; François P; Jouanneau E; Passagia JG; Bernier M; Cornélius A; Figarella-Branger D; Trouillas J; Borson-Chazot F; Brue T
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4592-9. PubMed ID: 20660056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. UPDATE ON THE CLINICOPATHOLOGY OF PITUITARY ADENOMAS.
    Lim CT; Korbonits M
    Endocr Pract; 2018 May; 24(5):473-488. PubMed ID: 29498920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas.
    Foltran RK; Amorim PVGH; Duarte FH; Grande IPP; Freire ACTB; Frassetto FP; Dettoni JB; Alves VA; Castro I; Trarbach EB; Bronstein MD; Jallad RS
    Braz J Med Biol Res; 2018 Jun; 51(9):e7427. PubMed ID: 29947650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pediatric Pituitary Adenomas: Early and Long-Term Surgical Outcome in a Series of 85 Consecutive Patients.
    Barzaghi LR; Losa M; Capitanio JF; Albano L; Weber G; Mortini P
    Neurosurgery; 2019 Jul; 85(1):65-74. PubMed ID: 29790934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinically silent corticotroph tumors of the pituitary gland.
    Scheithauer BW; Jaap AJ; Horvath E; Kovacs K; Lloyd RV; Meyer FB; Laws ER; Young WF
    Neurosurgery; 2000 Sep; 47(3):723-9; discussion 729-30. PubMed ID: 10981760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of temozolomide in aggressive pituitary tumors: case report.
    Mohammed S; Kovacs K; Mason W; Smyth H; Cusimano MD
    Neurosurgery; 2009 Apr; 64(4):E773-4; discussion E774. PubMed ID: 19349807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overview of the 2017 WHO Classification of Pituitary Tumors.
    Mete O; Lopes MB
    Endocr Pathol; 2017 Sep; 28(3):228-243. PubMed ID: 28766057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas.
    Losa M; Bogazzi F; Cannavo S; Ceccato F; Curtò L; De Marinis L; Iacovazzo D; Lombardi G; Mantovani G; Mazza E; Minniti G; Nizzoli M; Reni M; Scaroni C
    J Neurooncol; 2016 Feb; 126(3):519-25. PubMed ID: 26614517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes.
    Uraki S; Ariyasu H; Doi A; Takeshima K; Morita S; Inaba H; Furuta H; Fukuhara N; Inoshita N; Nishioka H; Nakao N; Yamada S; Akamizu T
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience.
    Langlois F; Lim DST; Varlamov E; Yedinak CG; Cetas JS; McCartney S; Dogan A; Fleseriu M
    Endocrine; 2017 Dec; 58(3):528-534. PubMed ID: 29043561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Aggressive Pituitary Adenomas: A Case-Based Narrative Review.
    Cooper O; Bonert V; Liu NA; Mamelak AN
    Front Endocrinol (Lausanne); 2021; 12():725014. PubMed ID: 34867776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The genetics of pituitary adenomas.
    Vandeva S; Jaffrain-Rea ML; Daly AF; Tichomirowa M; Zacharieva S; Beckers A
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):461-76. PubMed ID: 20833337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
    Daly AF; Vanbellinghen JF; Khoo SK; Jaffrain-Rea ML; Naves LA; Guitelman MA; Murat A; Emy P; Gimenez-Roqueplo AP; Tamburrano G; Raverot G; Barlier A; De Herder W; Penfornis A; Ciccarelli E; Estour B; Lecomte P; Gatta B; Chabre O; Sabaté MI; Bertagna X; Garcia Basavilbaso N; Stalldecker G; Colao A; Ferolla P; Wémeau JL; Caron P; Sadoul JL; Oneto A; Archambeaud F; Calender A; Sinilnikova O; Montañana CF; Cavagnini F; Hana V; Solano A; Delettieres D; Luccio-Camelo DC; Basso A; Rohmer V; Brue T; Bours V; Teh BT; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1891-6. PubMed ID: 17244780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and Pathological Aspects of Silent Pituitary Adenomas.
    Drummond J; Roncaroli F; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2473-2489. PubMed ID: 30020466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene.
    Jennings JE; Georgitsi M; Holdaway I; Daly AF; Tichomirowa M; Beckers A; Aaltonen LA; Karhu A; Cameron FJ
    Eur J Endocrinol; 2009 Nov; 161(5):799-804. PubMed ID: 19684062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of Crooke's changes in recurrence and remission after gamma knife radiosurgery.
    Cordeiro D; Xu Z; Nasser M; Lopes B; Vance ML; Sheehan J
    J Neurooncol; 2019 Mar; 142(1):171-181. PubMed ID: 30607704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53.
    Kasuki Jomori de Pinho L; Vieira Neto L; Armondi Wildemberg LE; Gasparetto EL; Marcondes J; de Almeida Nunes B; Takiya CM; Gadelha MR
    Neuroendocrinology; 2011; 94(1):39-48. PubMed ID: 21178332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review.
    Sahli R; Christ ER; Seiler R; Kappeler A; Vajtai I
    Pathol Res Pract; 2006; 202(6):457-64. PubMed ID: 16497445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pediatric pituitary adenoma: a series of 42 patients.
    Pandey P; Ojha BK; Mahapatra AK
    J Clin Neurosci; 2005 Feb; 12(2):124-7. PubMed ID: 15749410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paediatric pituitary adenomas: a decade of change.
    Guaraldi F; Storr HL; Ghizzoni L; Ghigo E; Savage MO
    Horm Res Paediatr; 2014; 81(3):145-55. PubMed ID: 24525527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.